carbapenems has been researched along with bo 2727 in 14 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (bo 2727) | Trials (bo 2727) | Recent Studies (post-2010) (bo 2727) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 15 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahi, Y; Miyazaki, S; Yamaguchi, K | 1 |
| Fuse, A; Hashizume, T; Hazumi, N; Matsuda, K; Sanada, M | 1 |
| Hata, S; Kagami, Y; Kuwabara, Y; Takano, T | 1 |
| Bruhin, PJ; Lin, JH; Wong, BK | 1 |
| Hata, S; Kosuge, K; Nakagawa, S; Nakashima, M; Sanada, M; Uematsu, T | 1 |
| Fukatsu, H; Hashizume, T; Matsuda, K; Nakagawa, S; Okamoto, O; Sanada, M; Tanaka, N | 1 |
| Barry, AL; Fuchs, PC | 1 |
| Hashizume, T; Hazumi, N; Kato, Y; Matsuda, K | 1 |
| Hamana, Y; Inoue, K; Mitsuhashi, S | 1 |
| Hikida, M; Mitsuhashi, S; Mori, M; Nasu, T; Nishihara, T | 1 |
| Adachi, Y; Fuse, A; Hashizume, T; Kato, E; Nagano, R; Nakagawa, S; Ohtake, N; Okamoto, O; Shibata, K | 1 |
| Hashizume, T; Nakagawa, S; Nakamura, K | 1 |
| Kato, Y; Nishino, T; Otsuki, M | 1 |
| Fukatsu, H; Haga, Y; Kato, Y; Mitomo, R; Nakagawa, S; Ohtake, N; Okamoto, O; Yamamoto, K | 1 |
1 trial(s) available for carbapenems and bo 2727
| Article | Year |
|---|---|
Column-switching high-performance liquid chromatographic analysis of BO-2727, a new carbapenem antibiotic, in human plasma and urine by direct injection.
Topics: Anti-Infective Agents; Carbapenems; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents | 1994 |
13 other study(ies) available for carbapenems and bo 2727
| Article | Year |
|---|---|
In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Drug Resistance, Microbial; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1995 |
Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Mutation; Pseudomonas aeruginosa | 1995 |
Column-switching high-pressure liquid chromatographic method for the determination of a new carbapenem antibiotic, L-739,428, in rat and monkey plasma.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Chromatography, High Pressure Liquid; Half-Life; Injections, Intravenous; Macaca mulatta; Rats | 1994 |
Pharmacokinetics and safety of BO-2727, a new injectable 1-beta-methyl carbapenem antibiotic, and its effect on the faecal microflora in healthy male volunteers.
Topics: Adolescent; Adult; Animals; Anti-Infective Agents; Blood Chemical Analysis; Carbapenems; Dogs; Feces; Half-Life; Haplorhini; Hemodynamics; Humans; Male; Pilot Projects; Rats | 1994 |
In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Dipeptidases; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrolysis; Imipenem; Kidney; Meropenem; Microbial Sensitivity Tests; Pseudomonas; Thienamycins | 1993 |
BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteria.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Diffusion; Imipenem; Meropenem; Microbial Sensitivity Tests; Predictive Value of Tests; Thienamycins | 1995 |
Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Synergism; Enzyme Inhibitors; Imipenem; Meropenem; Pseudomonas aeruginosa; Sulbactam; Thienamycins | 1995 |
In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.
Topics: Bacteria; beta-Lactamases; Carbapenems; Drug Stability; Microbial Sensitivity Tests | 1995 |
Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase-I.
Topics: Anti-Bacterial Agents; Carbapenems; Dipeptidases; Doripenem; Drug Stability; Humans; Lactams; Recombinant Proteins | 1996 |
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
Topics: Animals; Carbapenems; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Male; Meropenem; Mice; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1997 |
Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
Topics: Bacterial Proteins; Carbapenems; Carrier Proteins; Escherichia coli; Hexosyltransferases; Kinetics; Methicillin Resistance; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus | 1997 |
Antibacterial properties of BO-2727, a new carbapenem antibiotic.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Pseudomonas aeruginosa | 1997 |
1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 1997 |